| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 755 | 847 | 751 | 1.240 | 1.205 | 172 | 0 | 57 | 1.009 | 540 |
| Gross Profit/Loss - EUR | -755 | -847 | -751 | -1.240 | -1.205 | -172 | 0 | -57 | -1.009 | -540 |
| Net Profit/Loss - EUR | -755 | -847 | -751 | -1.240 | -1.205 | -172 | 0 | -57 | -1.009 | -540 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacit S.r.l. Farmacia Elphis
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.187 | 7.650 | 9.124 | 8.519 | 7.925 | 7.775 | 7.602 | 7.626 | 7.603 | 7.553 |
| Current Assets | 1.369 | 962 | 640 | 642 | 29 | 1 | 1 | 4 | 101 | 181 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 635 | 625 | 613 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1.369 | 326 | 15 | 29 | 29 | 1 | 1 | 4 | 101 | 181 |
| Shareholders Funds | 9.357 | 8.415 | 9.570 | 8.155 | 6.792 | 6.491 | 6.347 | 6.309 | 5.281 | 4.712 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 199 | 197 | 193 | 1.006 | 1.162 | 1.285 | 1.256 | 1.321 | 2.423 | 3.022 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacit S.r.l. Farmacia Elphis